OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Management of hyperuricemia in asymptomatic patients: A critical appraisal
Antonio Brucato, Francesco Cianci, Carla Carnovale
European Journal of Internal Medicine (2020) Vol. 74, pp. 8-17
Open Access | Times Cited: 61
Antonio Brucato, Francesco Cianci, Carla Carnovale
European Journal of Internal Medicine (2020) Vol. 74, pp. 8-17
Open Access | Times Cited: 61
Showing 1-25 of 61 citing articles:
Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease
Claudio Borghi, Enrico Agabiti‐Rosei, Richard J. Johnson, et al.
European Journal of Internal Medicine (2020) Vol. 80, pp. 1-11
Closed Access | Times Cited: 290
Claudio Borghi, Enrico Agabiti‐Rosei, Richard J. Johnson, et al.
European Journal of Internal Medicine (2020) Vol. 80, pp. 1-11
Closed Access | Times Cited: 290
Update on the epidemiology, genetics, and therapeutic options of hyperuricemia.
Lijun Li, Yipeng Zhang, Changchun Zeng
PubMed (2020) Vol. 12, Iss. 7, pp. 3167-3181
Closed Access | Times Cited: 163
Lijun Li, Yipeng Zhang, Changchun Zeng
PubMed (2020) Vol. 12, Iss. 7, pp. 3167-3181
Closed Access | Times Cited: 163
Hyperuricemia, the heart, and the kidneys – to treat or not to treat?
Tadej Petreski, Robert Ekart, Radovan Hojs, et al.
Renal Failure (2020) Vol. 42, Iss. 1, pp. 978-986
Open Access | Times Cited: 54
Tadej Petreski, Robert Ekart, Radovan Hojs, et al.
Renal Failure (2020) Vol. 42, Iss. 1, pp. 978-986
Open Access | Times Cited: 54
Why Does Hyperuricemia Not Necessarily Induce Gout?
Wei‐Zheng Zhang
Biomolecules (2021) Vol. 11, Iss. 2, pp. 280-280
Open Access | Times Cited: 53
Wei‐Zheng Zhang
Biomolecules (2021) Vol. 11, Iss. 2, pp. 280-280
Open Access | Times Cited: 53
The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics
Xinghong Wu, Chongge You
PeerJ (2022) Vol. 11, pp. e14554-e14554
Open Access | Times Cited: 36
Xinghong Wu, Chongge You
PeerJ (2022) Vol. 11, pp. e14554-e14554
Open Access | Times Cited: 36
Distinct Gut Microbiota in Patients with Asymptomatic Hyperuricemia: A Potential Protector against Gout Development
Hye Won Kim, Eun-Jeong Yoon, Seok Hoon Jeong, et al.
Yonsei Medical Journal (2022) Vol. 63, Iss. 3, pp. 241-241
Open Access | Times Cited: 30
Hye Won Kim, Eun-Jeong Yoon, Seok Hoon Jeong, et al.
Yonsei Medical Journal (2022) Vol. 63, Iss. 3, pp. 241-241
Open Access | Times Cited: 30
Lifestyle-Related Risk Factors for the Incidence and Progression of Chronic Kidney Disease in the Healthy Young and Middle-Aged Population
Akihiro Kuma, Akihiko Kato
Nutrients (2022) Vol. 14, Iss. 18, pp. 3787-3787
Open Access | Times Cited: 30
Akihiro Kuma, Akihiko Kato
Nutrients (2022) Vol. 14, Iss. 18, pp. 3787-3787
Open Access | Times Cited: 30
Associations of triglyceride-glucose index with hyperuricemia among Royal Thai Army personnel
Sethapong Lertsakulbunlue, Tanatip Sangkool, Varathpavee Bhuriveth, et al.
BMC Endocrine Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Sethapong Lertsakulbunlue, Tanatip Sangkool, Varathpavee Bhuriveth, et al.
BMC Endocrine Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
The Impact of Uric Acid and Hyperuricemia on Cardiovascular and Renal Systems
Davide Agnoletti, Arrigo F.G. Cicero, Claudio Borghi
Cardiology Clinics (2021) Vol. 39, Iss. 3, pp. 365-376
Closed Access | Times Cited: 35
Davide Agnoletti, Arrigo F.G. Cicero, Claudio Borghi
Cardiology Clinics (2021) Vol. 39, Iss. 3, pp. 365-376
Closed Access | Times Cited: 35
Uric acid en route to gout
Wei‐Zheng Zhang
Advances in clinical chemistry (2023), pp. 209-275
Closed Access | Times Cited: 12
Wei‐Zheng Zhang
Advances in clinical chemistry (2023), pp. 209-275
Closed Access | Times Cited: 12
Prevalence of High-Altitude Polycythemia and Hyperuricemia and Risk Factors for Hyperuricemia in High-Altitude Immigrants
Zhen Song, Anxin Zhang, Jie Luo, et al.
High Altitude Medicine & Biology (2023) Vol. 24, Iss. 2, pp. 132-138
Closed Access | Times Cited: 11
Zhen Song, Anxin Zhang, Jie Luo, et al.
High Altitude Medicine & Biology (2023) Vol. 24, Iss. 2, pp. 132-138
Closed Access | Times Cited: 11
Longitudinal associations between metabolic score for visceral fat and hyperuricemia in non-obese adults
Xingzhen Liu, D Chen, Xia Xu, et al.
Nutrition Metabolism and Cardiovascular Diseases (2020) Vol. 30, Iss. 10, pp. 1751-1757
Closed Access | Times Cited: 28
Xingzhen Liu, D Chen, Xia Xu, et al.
Nutrition Metabolism and Cardiovascular Diseases (2020) Vol. 30, Iss. 10, pp. 1751-1757
Closed Access | Times Cited: 28
Association between urate-lowering therapy and kidney failure in patients with chronic kidney disease
Agathe Mouheb, Oriane Lambert, Natalia Alencar de Pinho, et al.
Journal of Nephrology (2025)
Closed Access
Agathe Mouheb, Oriane Lambert, Natalia Alencar de Pinho, et al.
Journal of Nephrology (2025)
Closed Access
Ethanol Extracts from Torreya grandis Seed Have Potential to Reduce Hyperuricemia in Mouse Models by Influencing Purine Metabolism
Jianghui Yao, Enhe Bai, Yanwen Duan, et al.
Foods (2024) Vol. 13, Iss. 6, pp. 840-840
Open Access | Times Cited: 3
Jianghui Yao, Enhe Bai, Yanwen Duan, et al.
Foods (2024) Vol. 13, Iss. 6, pp. 840-840
Open Access | Times Cited: 3
The Association of Serum Uric Acid with Beta-Cell Function and Insulin Resistance in Nondiabetic Individuals: A Cross-Sectional Study
Yu Peng, Li Huang, Zhihan Wang, et al.
Diabetes Metabolic Syndrome and Obesity (2021) Vol. Volume 14, pp. 2673-2682
Open Access | Times Cited: 20
Yu Peng, Li Huang, Zhihan Wang, et al.
Diabetes Metabolic Syndrome and Obesity (2021) Vol. Volume 14, pp. 2673-2682
Open Access | Times Cited: 20
Asymptomatic Hyperuricemia as an Independent Risk Factor for Myocardial Infarction in Adult Population: A Four-Year Follow-Up Study
Abdul Subhan Talpur, Abdul Fattah, Hewad Hewadmal, et al.
Cureus (2023)
Open Access | Times Cited: 6
Abdul Subhan Talpur, Abdul Fattah, Hewad Hewadmal, et al.
Cureus (2023)
Open Access | Times Cited: 6
Prevalence of and risk factors for high-altitude hyperuricaemia in Bai individuals: a cross-sectional study
Chenni Gao, Zijin Chen, Jun Ma, et al.
Journal of International Medical Research (2021) Vol. 49, Iss. 7
Open Access | Times Cited: 11
Chenni Gao, Zijin Chen, Jun Ma, et al.
Journal of International Medical Research (2021) Vol. 49, Iss. 7
Open Access | Times Cited: 11
The Therapeutic Management of Chemical and Herbal Medications on Uric Acid Levels and Gout: Modern and Traditional Wisdom
Zhijian Lin, Jeetendra Kumar Gupta, Mohsin Maqbool, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1507-1507
Open Access | Times Cited: 1
Zhijian Lin, Jeetendra Kumar Gupta, Mohsin Maqbool, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1507-1507
Open Access | Times Cited: 1
Burden and correlates of cognitive impairment among hypertensive patients in Tanzania: a cross-sectional study
Pédrö Pallangyo, Zabella Mkojera, Makrina Komba, et al.
BMC Neurology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Pédrö Pallangyo, Zabella Mkojera, Makrina Komba, et al.
BMC Neurology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Serum uric acid in patients with ST-segment elevation myocardial infarction: An innocent bystander or leading actor?
Vilma Kajana, Gianluca Massaro, Alberto Somaschini, et al.
Nutrition Metabolism and Cardiovascular Diseases (2022) Vol. 32, Iss. 7, pp. 1583-1589
Closed Access | Times Cited: 5
Vilma Kajana, Gianluca Massaro, Alberto Somaschini, et al.
Nutrition Metabolism and Cardiovascular Diseases (2022) Vol. 32, Iss. 7, pp. 1583-1589
Closed Access | Times Cited: 5
Effects of uric acid-lowering therapy in patients with essential arterial hypertension
Krystian Gruszka, Tomasz Dróżdż, Wiktoria Wojciechowska, et al.
Blood Pressure Monitoring (2022) Vol. 27, Iss. 3, pp. 152-160
Open Access | Times Cited: 5
Krystian Gruszka, Tomasz Dróżdż, Wiktoria Wojciechowska, et al.
Blood Pressure Monitoring (2022) Vol. 27, Iss. 3, pp. 152-160
Open Access | Times Cited: 5
Antioxidant activity, xanthine oxidase inhibition and acute oral toxicity of Dillenia philippinensis Rolfe (Dilleniaceae) leaf extract
Sarah S. Ansari, Patricia H. Diño, Agnes L. Castillo, et al.
Journal of Pharmacy & Pharmacognosy Research (2021) Vol. 9, Iss. 6, pp. 846-858
Open Access | Times Cited: 6
Sarah S. Ansari, Patricia H. Diño, Agnes L. Castillo, et al.
Journal of Pharmacy & Pharmacognosy Research (2021) Vol. 9, Iss. 6, pp. 846-858
Open Access | Times Cited: 6
Risk factors and management of hyperuricemia after renal transplantation
Xiaoyu Zi, Xi Zhang, Chuan Hao, et al.
Frontiers in Surgery (2023) Vol. 9
Open Access | Times Cited: 2
Xiaoyu Zi, Xi Zhang, Chuan Hao, et al.
Frontiers in Surgery (2023) Vol. 9
Open Access | Times Cited: 2
¿Debemos manejar la hiperuricemia asintomática para proteger al riñón?
Alberto Francisco Rubio-Guerra, Carolina Guerrero García
Revista Colombiana de Nefrología (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Alberto Francisco Rubio-Guerra, Carolina Guerrero García
Revista Colombiana de Nefrología (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Recent Updates on Transdermal Drug Delivery Approaches for the Management of Gout and its Clinical Perspective
Ranjit K. Harwansh, Soumya Mishra, Rupa Mazumder, et al.
Current Pharmaceutical Biotechnology (2023) Vol. 25, Iss. 2, pp. 159-178
Closed Access | Times Cited: 2
Ranjit K. Harwansh, Soumya Mishra, Rupa Mazumder, et al.
Current Pharmaceutical Biotechnology (2023) Vol. 25, Iss. 2, pp. 159-178
Closed Access | Times Cited: 2
